Testing effectiveness (Phase 2)Ended earlyNCT02395627
What this trial is testing
Reversing Therapy Resistance With Epigenetic-Immune Modification
Who this might be right for
Breast Neoplasms
University of California, San Francisco 38
Showing 20 of 60 results